Similar effectiveness was observed by combining 227Th-targeted with an anti-fibroblast growth factor receptor 2 (FGFR2-TTC) and ATRi, leading to increased levels of γH2AX and cell cycle arrest compared to using either treatment alone in various cancer cells [173]. This evidence concerns the gene FGFR2 and cancer.